Well, if you have patience, time, and funds to invest, you could potentially make this a reality.

How can you earn $50,000 of income each year from ASX dividend shares?

One way to potentially achieve this is to invest in dividend-paying ASX shares which have strong long-term growth potential.

One example that I like to use to demonstrate how this has been achievable in the past is debt collector Credit Corp Group Limited (ASX: CCP).

There's nothing particularly revolutionary about the Credit Corp business model. It's just very good at what it does and operates in a large and growing market.

Ten years ago you could have picked it up for $1.28 per share. Since then its shares have increased dramatically in value and recently reached an all-time high of $27.38.

This strong share price gain has been driven by the company growing its earnings by an average of 20.7% per annum over the last decade.

But that's not the only thing that has been growing strongly over the period. Credit Corp has grown its dividend at an even quicker pace of 36.8% per annum over the last 10 years.

Pleasingly for shareholders, this dividend is expected to increase again this year. A note out of Morgans in April estimates that Credit Corp will pay a dividend of 75 cents per share fully franked in FY 2019.

This means that if you bought just over $85,000 worth of its shares 10 years ago (approximately 66,667 shares), those shares would yield $50,000 of fully franked dividends this year.

And let's not forget the incredible capital gains that you would have made over the period after watching its shares rise from $1.28 to $27.38.

But that was then and this is now. Where is the next Credit Corp?

Without a time machine or the DeLorean from Back to the Future, it is impossible to know which shares will do this over the next 10 years.

But I believe you can narrow down the search by looking at shares with strong growth potential, reasonable insider ownership, and favourable dividend policies. And rather than going all-in on one of them, try to spread your investment across a number of options.

One option could be Citadel Group Ltd (ASX: CGL). It is a specialist in managing information in complex environments through integrating know-how, systems and people to provide information on an anywhere-anytime basis. I believe it has outstanding long-term growth potential.

Another option could be content, collaboration, and process management solution provider Objective Corporation Limited (ASX: OCL), which has been growing its dividend strongly for a number of years. And if its shift to a subscription revenue model is a success, this trend could continue for a long time to come.

The post How you can earn $50,000 of income each year from ASX dividend shares appeared first on The Motley Fool Australia.

Here's a quick recap of global markets:

• FTSE 100 (UK): up 0.3%
• DAX (Germany): up 0.4%
• CAC 40 (France): up 0.7%
• Dow Jones (USA): up 0.6%
• NASDAQ (USA): up 0.8%

Here are today's key stats:

• ASX 200: up 0.9%
• All Ordinaries: up 0.8%
• Australian dollar (A$) (AUDUSD): 73.90 cents
• Gold price: down 0.5%
• WTI Crude Oil: down 0.6%
• Iron ore: Down 1.8% to $US55.97 per tonne, according to The Metal Bulletin

Leading the ASX higher were shares of Suncorp Group (ASX: SUN) and mining company Alumina Limited (ASX: AWC). Yesterday, Suncorp held its investor day presentations. However, no material news was released by Alumina.

Further down the market, NIB Holdings Limited (ASX: NHF) rebounded from its recent selloffs following news of legal battle with the ACCC, while Platinum Asset Management Limited (ASX: PTM) ended 3.2% higher. In the small cap space, lithium miner Orocobre Limited (ASX: ORE) traded 5% higher while skincare technology business OBJ Limited (ASX: OBJ) ended 7.7% higher.

Holding back the ASX were shares Blackmores Limited (ASX: BKL) and AGL Energy Ltd (ASX: AGL). AGL, the energy business, finished 3.9% lower after Macquarie analysts slapped the company's shares with an underperform rating.

Meanwhile, Blackmores recently confirmed that will move into the marijuana industry.

Here are today's top stories:

• Why the Janus Henderson Group share price is looking up
• 2 reasons I'm not buying Commonwealth Bank of Australia shares
• 7 "cheap" ASX shares to watch in June
• 2 healthcare shares to pounce on at a lower price
• 3 technology trends that could make you rich

The post ALL ORDINARIES finishes higher Friday: 8 shares you missed appeared first on The Motley Fool Australia.

Four shares which are having an even stronger finish to the week are listed below. Here's why they are ending the week with a bang:

The Fletcher Building Limited (Australia) (ASX: FBU) share price is up 3% to $7.36 today thanks to a positive research note out of Deutsche Bank. Its analysts reiterated their buy rating on its shares after its research showed that New Zealand construction demand remains strong. If this proves to be the case then Fletcher Building could prove to be great value for money in my opinion.

The Orocobre Limited (ASX: ORE) share price is up 5.5% to $3.85 despite there being no news out of the lithium miner. A presentation released by rival Galaxy Resources Limited (ASX: GXY) today could be behind the gain. Galaxy's presentation shows that the lithium-ion battery application mix is transitioning from being dominated by consumer electrics to new energy vehicle applications. It believes the strong demand will support the high prices lithium is currently commanding.

The OBJ Limited (ASX: OBJ) share price is up almost 8% to 5.6 cents after the drug delivery technology company provided a trading update. According to the release OBJ received $127,400 of royalties from its skincare technology licensee in the March quarter. Furthermore, the company has received its first standstill and royalty fees of approximately $169,000 for the second technology licensed to global giant Procter & Gamble.

The Zelda Therapeutics Ltd (ASX: ZLD) share price has rocketed 32% to 7.4 cents after the medicinal cannabis company reported positive results from its ongoing pre-clinical research into the use of cannabinoids as anti-cancer agents. A series of in vitro studies have confirmed that both THC-rich and CBD-rich oils have had a statistically significant anti-cancer effect across a range of different breast cancer cell lines.

The post Why these 4 ASX shares are ending the week with a bang appeared first on The Motley Fool Australia.

These five companies all went against the trend, posting strong gains…

Stanmore Coal Limited (ASX: SMR) share price gained 18.2% to $0.71.5, and is now up nearly 400% since the start of the year. The company bought the Isaac Plains metallurgical coal mine for just $1 in July last year from Vale and Sumitomo Corp as coal prices slumped to near decade-lows of around US$70 a tonne. One year on and the spot coal price is now above US$200 a tonne and Stanmore may have got the bargain of the century. Overnight, the coal price rose again, hitting US$218.10 a tonne according to Steel Index.

OBJ Limited (ASX: OBJ) share price gained 8.5% to 7.7 cents, after the company announced that it had been granted two new US patents for its magnetic microarray technology used in skincare and oral healthcare. The company is a small biotech focusing on providing transdermal and intra-dermal drug delivery as well as therapeutic and dermatological skincare, and you can find more details here.

Karoon Gas Australia Limited (ASX: KAR) share price gained 7.5% to $1.795, after publishing an operations review yesterday. The oil and gas explorer saw its share price zoom higher last week after it announced that the company was buying a stake in two oil projects, including one that is producing 45,000 barrels of oil a day. It seems investors are still highly optimistic about the deal – even though the company hasn't said how much it is paying for the stakes.

Money3 Corporation Limited (ASX: MNY) share price gained 7.4% to $1.805, after broker Bell Potter initiated coverage on the company with a Buy rating and a 12-month price target of $2.40. The broker thinks there are several reasons why the shares are worth much more than the current price – including trading on a P/E ratio of just 10x its FY2017 earnings and strong earnings per share growth last year, and also ahead in the next few years.

Cardno Limited (ASX: CDD) share price gained 7.7% to $1.12. Over the past week, the share price has surged over 20%, despite no news from the company. Some investors could be punting on Cardno receiving another takeover offer, after all, Bradken Limited (ASX: BKN) received its fifth and most likely final takeover offer earlier this month. Cardno offers infrastructure and environmental services but has struggled as the resources boom slowly dies. Last year the company received a proportional takeover valued at $3.15 per share – current shareholders may well be crying.

The post 5 shares soaring on the ASX today appeared first on The Motley Fool Australia.

OBJ has developed a technology which uses magnetic repulsion to push molecules through the skin. The company has shown that their method significantly improves the delivery of certain skincare products.

The company is targeting the fast moving consumer goods market (FMCG) and has a product development agreement (PDA) with behemoth Proctor & Gamble (P&G). The agreement covers multiple product categories and the fact that such a recognised industry name is collaborating with OBJ suggests the technology has significant potential.

To date, just one product has been released which uses OBJ's technology, the Wave 1 Eye Wand, sold as part of P&G's SK-II brand. However, the company is hoping to develop multiple products with P&G as well as sell its technology through other partners.

OBJ recorded revenue of just $1.4 million in the first half of 2016 up from $1.1 million in the prior year. Despite this, the company is capitalised at $163.3 million and so the market seems to be optimistic about its future.

That optimism could have something to do with the tone of the company's public communication. For example, in The Australian's article chairman Glyn Denison is quoted as saying,

"As it grows, this company will be a significant pharmaceutical company in Australia in its own right. It's only a matter of time."

Similarly, founder and director Jeffrey Edwards says when speaking about the company's deal with P&G,

"We are at the heart of their whole innovation."

I am not a fan of companies that make such bold claims, especially when the individuals making them have been reducing their shareholdings over the last couple of years.

I actually used to own shares in OBJ and was lucky enough to double my money when the company signed its PDA with P&G in April 2014. I sold them shortly afterwards when I belatedly figured that profitability was still some years away.

For me, the trouble with stocks like OBJ is that there is simply not enough information available to come up with an approximate valuation. I would rather focus on profitable businesses, or at least those with significant revenues.

The post Why did OBJ Limited surge today? appeared first on The Motley Fool Australia.

I've run my eye over the list of companies that have delivered gains of over 500% in the last 12 months and found three great examples of small, speculative companies that have already made investors rich, but could still rise further.

The leader, with a 1,700% return over 12 months, is Cynata Therapeutics Ltd (ASX: CYP). Cynata's stem cell technology aims to mass produce synthetic Mesenchymal Stem Cells that are used for heart repair, to rebuild bone and cartilage, and reduce inflammation. The production process is being researched now and once complete might be a catalyst for another jump in the share price.

Running close second with a 1,500% return is investor favourite Liquefied Natural Gas Limited (ASX: LNG). LNG has a revolutionary gas technology and production licences that investors expect to support huge profits in the future.

Third, with a less impressive but still massive return of 550% is OBJ Limited (ASX: OBJ). OBJ has developed a method of increasing the penetration of cosmetics into the skin with the use of magnets. While that description sounds unimpressive, the company is working with giants of the healthcare industry to develop its products.

These massive returns are possible for everyday investors, however remember that speculative stocks should only comprise a small percentage of your portfolio. There's another company worth investigating which is not so speculative, but The Motley Fool thinks it could be huge. This small-cap tech stock has had a good run but could go much further.

The post Could these 3 speculative stocks make you rich? appeared first on The Motley Fool Australia.